Background-Cholangitis, an infection of the biliary tract, is most commonly caused by Gram negative bacteria, particularly Escherichia coli. Factors preparing the skin with povidone-iodine solution (Betadine). At the conclusion of the procedure, the abdomen was closed in two layers using 5-0 Dexon and 4-0 silk. Live E coli (104-106 organisms in 0.1 ml of sterile normal saline) were then introduced into the bile duct, the cannula was removed, and the bile duct was ligated. Seventy two hours later, all surviving animals were anaesthetised by intra-peritoneal injection of pentobarbital sodium, and 1 ml of blood was obtained by sterile cardiac puncture for blood culture. The animals were then immediately killed as previously described. Bile and the right lobe of the liver were removed for postmortem analysis. Group 2 experimental rats (n=24) were immunised by injecting 2.5x108 formalin killed E coli into Peyer's patches as previously described. Seven days later, 12 of these rats were orally boosted via a blunt ended feeding needle with 69X 108 killed E coli, and the remaining 12 rats were orally boosted with 6.9X 108 killed E coli plus 0.04 mg whole cholera toxin (List Biological Laboratories, Campbell, California). Control rats (n= 12) had sterile normal saline injected into their Peyer's patches, followed by sham oral boosting with saline seven days later. Five days after boosting, the common bile duct was cannulated, bile was collected, and 107 live E coli were introduced into the common bile duct, which was then ligated. Seventy two hours later, any surviving rats were killed in the same fashion as for group 1 rats. Intra-cardiac blood, bile, and the entire liver were collected for analysis.
ELISA for anti-E coli IgA in bile The wells of flexible assay plates (Falcon 3912; Becton Dickinson, Oxnard, Califomia) were coated with 100 1 of formalin killed E coli (108 organisms/ml suspended in 1M sodium carbonate, pH 9.5) for four hours at 25°C. 1 After washing with phosphate buffered saline (Dulbecco's PBS, pH 7-5; Sigma Chemical Co, St Louis, Missouri), the wells were blocked with 1% bovine serum albumin in deionised H20 (essential fatty acid free bovine albumin; Sigma Chemical Co) for two hours at 25°C. After washing with PBS, 1 0l0oo of bile (diluted in PBS from 1:50 to 1:3200) were added to duplicate wells, and the plates were incubated ovemight at 4°C. The plates were again washed with PBS, and 100,l of 1:1000 peroxidase conjugated antirat IgA (Zymed Laboratories Inc, South San Francisco, Califomia) were added to the wells, and the plates were incubated for four hours at 25'C. After washing the plates with PBS, 1 00,I of substrate solution consisting of 25 ml citrated phosphate buffer (pH 5.0), 1O,I 30% hydrogen peroxide, and 10 mg 0-phenylenediamine (Sigma Chemical Co) were added to the wells, and the reaction was allowed to proceed for In phase 2 group rats, a 2-0 g piece of the right hepatic lobe was mechanically ground into a homogenate by trituration with sterile glass beads, and the homogenate was suspended in 2 ml of sterile normal saline. A 50 ,ul unfiltered aliquot of each homogenate was plated and cultured overnight at 37°C, and bacterial colonies were counted the next morning. The entire liver was removed from rats in phase 2 group 2. It was weighed and homogenised, and the homogenate was suspended in 20 ml of sterile normal saline. Each sample was filtered through fine mesh sterile gauze. A 100 ,ul filtered aliquot of each suspension was serially diluted in sterile PBS to a dilution of 1:30 000; four 20 ,ul drops of each diluted sample were plated to make four rows on a Mueller-Hinton agar plate. Phase 1 Bile collected at 3, 5, 7, 9, and 14 days after injection from immunised and control rats was analysed by ELISA for anti-E coli IgA ('specific IgA'). Specific IgA was present in bile samples collected from immunised rats 7, 9, and 14 days after immunisation (data not shown).
Phase 2, group 1 Bile collected seven days after Peyer's patch injection with killed E coli (immunised rats) or with sterile saline (control rats) was analysed by ELISA. Specific IgA levels, expressed as OD490 values, were higher in bile from immunised rats than from controls, confirming immunisation (Fig 1) . Western blotting showed that rats injected with killed E coli generated a biliary IgA response to multiple antigens of E coli (Fig  2) .
One of the 11 control rats died of sepsis 48 hours after bacterial inoculation of the common bile duct. A bile leak was found in one immunised rat at postmortem examination. One control and one immunised rat died of anaesthetic complications before the bacterial inoculation step. All other immunised rats (n=11) and control rats (n=9) surviv until death 72 hours after bacterial challenB lood, bile, and liver tissue collected death were cultured. E coli was present in b cultures from all rats in this group, but bloi cultures were negative for bacterial growl The results of the cultures of 50,u1 of undilut liver homogenates suggested there was inverse correlation between immunisation a. bacterial colony counts from the liver. F example, the mean bacterial colony count i liver homogenates from nine control rats M 523 per culture plate. The correspondi mean value for liver homogenates from immunised rats was 71 colonies per cultu plate. While these results were statistica significant (p=0043, Student's t test), only 2.0 g piece of the right hepatic lobe from rats in phase 2, group 1 was processed a] cultured. Concern arose over whether ti specimen was representative of bacterial dist bution throughout the liver. Therefore, check on the correlation between immunis tion and bacterial colony counts, the ent liver was processed and cultured in group rats.
Phase 2, group 2 The results of ELISA of bile samples from ti group of rats were similar to the correspondi results for group 1 rats, in that specific Is levels (OD490 values) were higher in bile frc immunised rats than from controls (Fig 3) .b difference was seen in specific IgA levi between rats orally boosted with E coli pl cholera toxin versus E coli alone (Fig 3) . T incidence of systemic sepsis after E c inoculation of the bile duct was 50/o in conti rats (six of 12 controls) compared with 4 (one of 24) in immunised rats (p=0005; test). Of the 12 control rats, four died of sep and two others were clinically septic wh A killed. All 12 rats injected with killed E coli and A boosted with killed E coli plus cholera toxin, B and 11 of 12 rats injected and boosted with killed E coli alone, survived until killed and were not bacteraemic or clinically septic. One rat that was immunised and boosted with killed E coli alone died of sepsis 48 hours after administration of viable E coli.
Blood, bile, and liver tissue were collected at death and cultured. Cultures of blood from the two control rats that were septic when killed grew E coli. There was no growth of E coli in blood cultures from the six control rats that were not septic when killed or from the 23 immunised rats that survived until killed. All bile cultures from immunised and control rats grew E coli. Serial dilution and culture of liver homogenates showed an inverse correlation (p=0.024; Student's t test) between immunisation and E coli colony counts (Fig 4) . 1:800 Dilution of bile ferred protection against a direct antigenic challenge in the hepatobiliary system. We found that high values of antigen specific biliary IgA were induced by immunisation, and that they did provide some protection from experimentally induced cholangitis. While the mechanism responsible for these effects has not been proved, the data suggest they are attributable to the induced specific IgA antibody.
Immunisation did not prevent infection altogether but mitigated its severity. The phase 2 rats, whether immunised or not, had cholangitis (culture results), but there was an inverse correlation between immunisation and the extent of infection. A correlation was suggested in the results from the group 1 rats (mean colony counts in controls versus immunised rats were 523 and 71, respectively). In group 2 rats this correlation was significant (Fig 4, p=0024, Student's t test), which suggested that the immunisation inhibited intrahepatic proliferation of E coli.
Immunisation with killed E coli also provided (phase 2, group 2) considerable protection against systemic sepsis. In group 1, despite higher levels of specific biliary IgA in immunised rats than in controls, the clinical course after bacterial challenge was similar.
We concluded from the group 1 data that, while an effect of immunisation was present (based on liver homogenate colony counts), the severity of the bacterial challenge was insufficient to change the overall clinical course. In group 2, the bacterial challenge was increased, and the clinical effects were more striking. As noted above, systemic sepsis was present in six of 12 control rats and in one of 24 immunised rats in group 2. Therefore, the data suggest that, in addition to inhibiting bacterial proliferation within the hepatobiliary system, immunisation inhibited bacterial translocation into the systemic circulation. This may result from antibody antigen complex formation, which is known to prevent epithelial attachment 6 
